Moderna/ US60770K1079 /
5/10/2024 9:59:27 PM | Chg. -5.29 | Volume | Bid10:25:00 PM | Ask1:19:12 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
117.31USD | -4.31% | 197,838 Turnover: 13.17 mill. |
110.00Bid Size: 4 | 121.54Ask Size: 1 | 44.96 bill.USD | - | - |
GlobeNewswire
5/8
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/8
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
5/2
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/1
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
5/1
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
4/4
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
3/4
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024